BR112022018315A2 - Regime para tratar a infecção por neisseria gonorrhoeae com gepotidacina - Google Patents

Regime para tratar a infecção por neisseria gonorrhoeae com gepotidacina

Info

Publication number
BR112022018315A2
BR112022018315A2 BR112022018315A BR112022018315A BR112022018315A2 BR 112022018315 A2 BR112022018315 A2 BR 112022018315A2 BR 112022018315 A BR112022018315 A BR 112022018315A BR 112022018315 A BR112022018315 A BR 112022018315A BR 112022018315 A2 BR112022018315 A2 BR 112022018315A2
Authority
BR
Brazil
Prior art keywords
gepotidacin
neisseria gonorrhoeae
regime
gonorrhoeae infection
treat
Prior art date
Application number
BR112022018315A
Other languages
English (en)
Inventor
Scangarella-Oman Nicole
Dumont Etienne
Bergesch Barth Aline
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of BR112022018315A2 publication Critical patent/BR112022018315A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

REGIME PARA TRATAR A INFECÇÃO POR NEISSERIA GONORRHOEAE COM GEPOTIDACINA. A presente invenção refere-se a um método de tratamento de uma infecção causada por Neisseria gonorrhoeae, compreendendo a administração de gepotidacina ou de um sal farmaceuticamente aceitável da mesma, a um humano que necessite da mesma, de acordo com um regime de tratamento conforme aqui definido.
BR112022018315A 2020-04-02 2020-04-02 Regime para tratar a infecção por neisseria gonorrhoeae com gepotidacina BR112022018315A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2020/000253 WO2021198715A1 (en) 2020-04-02 2020-04-02 Regimen for treating a neisseria gonorrhoeae infection with gepotidacin

Publications (1)

Publication Number Publication Date
BR112022018315A2 true BR112022018315A2 (pt) 2022-10-25

Family

ID=70978286

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022018315A BR112022018315A2 (pt) 2020-04-02 2020-04-02 Regime para tratar a infecção por neisseria gonorrhoeae com gepotidacina

Country Status (6)

Country Link
EP (1) EP4125905A1 (pt)
JP (1) JP2023528560A (pt)
CN (1) CN115335054A (pt)
BR (1) BR112022018315A2 (pt)
CA (1) CA3176961A1 (pt)
WO (1) WO2021198715A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024068524A1 (en) * 2022-09-26 2024-04-04 Glaxosmithkline Intellectual Property Development Limited Gepotidacin for use in the treatment of bacterial prostatitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
TW201444558A (zh) * 2013-03-15 2014-12-01 Melinta Therapeutics Inc 使用喹諾酮類抗生素治療淋病感染的方法
EA031589B1 (ru) 2014-08-22 2019-01-31 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Трициклические азотсодержащие соединения для лечения инфекции, вызываемой neisseria gonorrhoeae
MX2017006383A (es) * 2014-11-17 2017-08-21 Entasis Therapeutics Ltd Terapia de combinacion para el tratamiento de infecciones bacterianas resistentes.

Also Published As

Publication number Publication date
CN115335054A (zh) 2022-11-11
CA3176961A1 (en) 2021-10-07
EP4125905A1 (en) 2023-02-08
JP2023528560A (ja) 2023-07-05
WO2021198715A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
BR112020017090A8 (pt) Imunoterapias relacionadas com microbioma
BR112018016001A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
BR112018002046A2 (pt) métodos de tratamento da síndrome de lennox-gastaut usando fenfluramina
BR112021022778A2 (pt) Compostos e métodos para o tratamento de covid-19
CL2023001351A1 (es) Métodos de tratamiento de la insuficiencia cardíaca mediante la administración de omecamtiv mecarbil.
BR112019008384A2 (pt) composição farmacêutica, processos para tratamento e seus usos
EA202090242A1 (ru) Лечение болезни фабри у фзт-наивных и фзт-леченных пациентов
BR112023013033A2 (pt) Regimes de tratamento com dexmedetomidina
ECSP22086300A (es) Composiciones que comprenden nanopartículas, método de elaboración y usos de las mismas
BR112021024845A2 (pt) Combinação para o tratamento de infecções causadas por mycoplasma genitalium
BR112022018315A2 (pt) Regime para tratar a infecção por neisseria gonorrhoeae com gepotidacina
MX2021011269A (es) Tratamiento de enfermedades y trastornos asociados a las mitocondrias, incluyendo los sintomas de los mismos usando pridopidina.
BR112023021131A2 (pt) Tratamento de tremor essencial
MX2020008881A (es) Métodos de tratamiento contra el cáncer que comprenden inhibidores de chk1.
BR112015011099A2 (pt) Composições e métodos para o tratamento de diplasia ectodérmica
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
BR112022015533A2 (pt) Composições e métodos para tratar doenças oculares
BR112021020962A2 (pt) Métodos de tratamento de prurido
EA202192928A1 (ru) Терапевтическое лекарственное средство для лечения дискинезии
BR112023023702A2 (pt) Métodos de tratamento da cistite intersticial/síndrome da dor na bexiga
BR112023020669A2 (pt) Terapias de combinação para o tratamento de câncer
CL2021003312A1 (es) Composición que comprende pridopidina y un análogo de la misma para el tratamiento de la enfermedad de huntington y síntomas de la misma.
BR112019005217A2 (pt) terapia combinada
BR112023015440A2 (pt) Métodos de tratamento de câncer usando uma combinação de regimes de dosagem com serd
BR112022025741A2 (pt) Usos de composições compreendendo crofelemer para tratamento de diarreia induzida por quimioterapia (cid)